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Infrared radiation from cage 
bedding moderates rat 
inflammatory and autoimmune 
responses in collagen‑induced 
arthritis
Jasmina Djuretić1,6, Mirjana Dimitrijević2,6, Marija Stojanović1, Jelena Kotur Stevuljević3, 
Michael R. Hamblin4, Ana Micov5, Radica Stepanović‑Petrović5 & Gordana Leposavić1*
The development of collagen type II (CII)‑induced arthritis (CIA), a model of rheumatoid arthritis, in 
rats housed in cages with bedding composed of Celliant fibres containing ceramic particles, which 
absorb body heat and re‑emit the energy back to the body in the form of infrared radiation (+IRF rats), 
and those housed in cages with standard wooden shaving bedding (−IRF control rats) was examined. 
The appearance of the first signs of CIA was postponed, while the disease was milder (judging by 
the arthritic score, paw volume, and burrowing behaviour) in +IRF compared with −IRF rats. This 
correlated with a lower magnitude of serum anti‑CII IgG antibody levels in +IRF rats, and lower 
production level of IL‑17, the Th17 signature cytokine, in cultures of their paws. This could be partly 
ascribed to impaired migration of antigen‑loaded CD11b + dendritic cells and their positioning within 
lymph nodes in +IRF rats reflecting diminished lymph node expression of CCL19 /CCL21. Additionally, 
as confirmed in rats with carrageenan‑induced paw inflammation (CIPI), the infrared radiation from 
Celliant fibres, independently from immunomodulatory effects, exerted anti‑inflammatory effects 
(judging by a shift in pro‑inflammatory mediator to anti‑inflammatory/immunoregulatory mediator 
ratio towards the latter in paw cultures) and ameliorated burrowing behaviour in CIA rats.
As a result of substantial advances in polymer chemistry, relatively recently, infrared radiation-emitting (IR) fibres 
(filaments) have been developed. These fibres have a porous core-sheath and groove structure allowing various 
optically active ceramic micron-sized particles to be incorporated into each  fibre1,2. One type of these fibres is 
Celliant (Hologenix, Santa Monica, CA, USA), a polyethylene terephthalate fibre that incorporates micron-sized 
optically active ceramic particles exhibiting the property of temperature-dependent infrared emission. These 
fibres have been woven to get high-performance functional  textiles1,2. When such functional textiles are used as 
garments, bandages, or bed linen, the heat energy generated by the human body can be transferred by radiation, 
conduction, convection to the ceramic  particles1–4. These ceramic particles act as black-body absorbers and re-
emit the absorbed energy as infrared radiation back to the  body5. According to the classification of the Interna-
tional Commission on Illumination (CIE) and the classification provided in ISO 20473 standard (ISO 20473), 
infrared radiation has three broad categories: near infrared (0.7–1.4 μm and 0.78–3 μm according to CIE and 
ISO 20473, respectively), mid-infrared (0.4–3 μm and 3–50 μm according to CIE and ISO 20473, respectively) 
and far infrared (3–100 μm and 50–1000 μm according to CIE and ISO 20473, respectively). Considering the 
aforementioned data, IR fabrics are suggested to recycle the body’s natural  energy5. At physiological skin tempera-
ture, much of the body’s emissive radiative power is centered between 7 and 14 μm6,7. Generally, infrared radia-
tion penetrates deeply through the layers of the skin to reach the muscles and  bones8. This radiation moderates 
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 inflammation9,10 and  pain4. Additionally, it promotes tissue regeneration and wound healing by improving 
 circulation11,12 and/or acting directly on cells to improve mitochondrial  metabolism13, and thereby a number of 
cellular functions including energy generation, calcium signaling, and cell  growth14. Given that infrared radiation 
is non-invasive and painless, it could be a broadly applicable therapeutic option for moderating inflammation 
and pain 2,8. However, when this radiation is delivered from standard electrically-powered sources (such as IR 
heat lamps and IR saunas), it could cause a prolonged erythemal response due to excessive heating of the  skin2. 
Additionally, when the radiation is delivered from these sources, it is difficult to delineate effects related to the 
increase in the core body temperature (hyperthermia) from the direct biochemical effects on living  cells2. It is 
noteworthy that the infrared radiation that does not produce any detectable skin heating effects, such as the 
infrared radiation emitted by the ceramic particles enriched IR  fabrics2, can also produce biological  effects15,16. 
Indeed, IR fabrics that mainly rely on the energy emitted from the body have been found to reduce inflammation 
and  pain15, so their therapeutic use may be considered. In this context, it should be added that IR fabrics, may 
be worn for extended periods in the form of clothing or bandages or used as bed linen to attain health  benefits2. 
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease primarily affecting the lining of the 
synovial joints, and causing progressive disability, premature death, and high socioeconomic  burdens17,18. The 
clinical manifestations encompass symmetrical joint involvement including arthralgia (joint pain), swelling, red-
ness, and even a limited range of  motion17,18. Many immune and other cell types and their cytokines play roles in 
the development of  RA17,18. The synovial compartment is infiltrated with adaptive immune cells, including both 
T cells and B cells, and innate immune cells (monocytes and macrophages), which interact between themselves 
and with fibroblast-like synoviocytes to produce inflammatory  mediators17. Effector Th17 cells acting together 
with arthritogenic autoantibodies are suggested to be the major driver of non-resolving joint tissue damage, 
and therefore prolonged inflammation in  RA17,19. Monocytes/macrophages massively infiltrating the synovial 
membranes in  RA20,21, are shown to be central to the joint  inflammation22. The imbalance between monocyte/
macrophages with pro-inflammatory secretory profile and monocyte/macrophages with anti-inflammatory/
immunoregulatory secretory profile is suggested to be particularly important for RA development, as a shift 
towards the former contributes to osteoclastogenesis (i.e. production of osteoclasts, the cells specialized for bone 
resorption), and thereby to bone loss that ultimately leads to the destruction of the subchondral bone and the 
degeneration of the overlying articular cartilage 22,23. On the other hand, a shift towards monocyte/macrophages 
with anti-inflammatory/immunoregulatory secretory profile has been suggested to contribute to the regression 
of joint injury and inflammation in  RA24.
While there is currently no long-term cure for RA, the treatment strategy aims to alleviate arthralgia and 
rapidly achieve a lowering of the disease activity  state17. The introduction of novel disease-modifying anti-
rheumatic drugs (DMARDs) has dramatically improved the prognosis of RA patients, but a significant propor-
tion of these patients fail to report long-term relief of arthralgia, reflecting the incomplete disease  control17. In 
this context, significant efforts have been made to show that is important to put inflammation under control in 
the early phases of RA  development25. Additionally, even if treatment with DMARDs does reduce arthralgia, 
a proportion of RA patients is still dissatisfied with its management and continue to rate the pain relief as one 
of their top requirements for improved health and quality of  life17. Considering various side effects (including 
gastrointestinal disorders, immunosuppression, and humoral disturbances) of analgesics, which are most com-
monly used in RA, i.e. nonsteroidal anti-inflammatory drugs and corticosteroids, research into new options to 
control arthritis and arthralgia in RA is of great importance.
The most widely used RA model is rodent collagen type II (CII)-induced arthritis (CIA). This model has 
gained acceptance since it is reproducible, well defined, and particularly because it has proven useful for the 
development of new therapies for  RA26. It has also been recommended to use rats for studying the anti-arthritic 
effects of various agents, as rats are less variable than mice, their joints are bigger and the inflammatory changes 
are more  reproducible26.
The present study was primarily undertaken to examine the effects of exposure of rats to IR fibres used as cage 
bedding (mimicking exposure to IR fabrics used as bed linen) on the development of autoimmune inflammation 
of joints in the CIA model. The study included female Dark Agouti (DA) rats as compared with male rats, they 
exhibit a substantially higher incidence of CIA and more severe  disease27–29. In these rats, joint inflammation and 
burrowing behaviour were examined. We decided to evaluate burrowing behaviour as it was suggested to be a 
reliable tool to measure outcomes similar to those measured in the clinical trial evaluating effects of analgesics 
in chronic pain conditions (viz. spontaneous pain and overall patient healthy status), as it is  RA30. Additionally, 
to elucidate the putative mechanisms standing behind the effects of infrared radiation on the development of the 
inflammation of paw joints in CIA rats, the indicators of ongoing humoral (the serum levels of anti-CII-specific 
antibodies) and cellular (the production levels of IL-17, Th17 signature cytokine, in inflamed paw cultures from 
CIA rats) immune responses, and inflammatory response (the production levels of the key pro-inflammatory 
cytokines, i.e.TNF-α, IL-1β and PGE2 and NO, and anti-inflammatory/immunoregulatory mediators IL-10 and 
TGF-β in RA, in inflamed paw cultures)31–36 were examined. The main source of these mediators in RA are sug-
gested to be activated macrophages 31–36 Of note, macrophage activation is shown to be a dynamic process; the 
same cells may initially take part in proinflammatory and cytotoxic reactions and later participate in the resolu-
tion of inflammation and wound healing, so in an inflammatory microenvironment, they are “blend” together 
critically shaping the outcome of the  inflammation37. Given that the primary results showed that the exposure 
to IR fibres as cage bedding moderated development of both humoral and cellular immune responses, and that 
joint tissue-specific antibodies in RA/CIA may cause arthralgia in the absence of overt inflammation through 
direct action on sensory  neurons38, we extended our research to study the effects of exposure to IR fibres as 
cage bedding to the development of carrageenan-induced paw inflammation (CIPI), a model commonly used 
to assess the production of inflammatory mediators at sites of inflammation, the anti-inflammatory properties 
of agents such as nonsteroidal anti-inflammatory drugs, and the efficacy of putative analgesic compounds to 
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reverse cutaneous  hypersensitivity39. Given that rats from cages with bedding from IR fibres developed paw 
inflammation of lower magnitude compared with those from cages with standard wood shaving bedding, the 
effects of rat exposure to IR fibres in a treatment paradigm were examined, as well.
Materials and methods
Animals. In the present study four-month-old female Dark Agouti (DA) rats from a breeding colony in the 
Immunology Research Centre “Branislav Janković” (Belgrade, Serbia) were used. Rats were maintained in a fully 
controlled animal facility with a constant temperature (21–23 °C) and humidity (30–50%), a 12 h/12 h light/
dark cycle, and they were provided ad libitum access to water and standard pelleted food. All experiments were 
performed in accordance with the Directive 2010/63/EU of the European Parliament and of the Council on the 
Protection of Animals used for Scientific Purposes (revised Directive 86/609/EEC), and were approved by Labo-
ratory Animal Ethical Committee of University of Belgrade—Faculty of Pharmacy (Etička Komisija za ogledne 
životinje, Univerzitet u Beogradu –Farmaceutski fakultet).
Induction and clinical evaluation of CIA. Rats were immunised intradermally at the base of the tail with 
300 μg of bovine CII Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) emulsified in incomplete Freund’s 
adjuvant (IFA), as previously  described27,28. The immunisation emulsion was prepared by mixing equal volumes 
of CII solution (2 mg/mL) in 0.1 M acetic acid and IFA. For immunisation 300 µL of this emulsion was injected 
per rat. Before the immunisation, animals were anesthetized with an intraperitoneal injection of anesthetic cock-
tail [50 mg/kg/body weight (BW) of ketamine/5 mg/kg BW xylazine; Ketamidor, Richter Pharma AG, Wels, Aus-
tria; Xylased, Bioveta, Ivanovice na Hané, Czech Republic]. Clinical signs of arthritis were evaluated daily from 
the 7th day post immunisation (d.p.i.) until the 22nd d.p.i., when the clinical severity of the disease reaches the 
maximum 27,28. The severity of CIA was graded according to an arbitrary scale taking into account joint edema 
and erythema of the hind and front paws (one point for each inflamed metacarpophalangeal/metatarsophalan-
geal or interphalangeal joint, and five points for the inflamed ankle)40 by two experienced researchers (MD and 
MS), independently. Thus, each paw could receive the maximum score of 15 points giving the highest arthritic 
score of 60. Additionally, paw volumes were measured before the immunisation (basal) and on the 22nd d.p.i. 
Given that pathological changes predominantly occurred in the hind paws of rats, volumes of both hind paws 
were measured. Of note, these measurements and all subsequent analyses were conducted by two investigators 
blind to the rat cage bedding.
Induction and clinical evaluation of CIPI. Paw inflammation was induced by intraplantar injection of 
1.5 mg carrageenan (λ-carrageenan, Sigma Aldrich, St.Louis, MO, USA) in 150 μL saline or 150 μL of saline 
(controls) into the right hind paw starting from the midline near the heel and continuing toward the base of the 
second or third toe as previously  described39. The volumes of their right hind paws were measured before injec-
tion of carrageenan or saline (basal) and four times afterward at one hour intervals. The temperature of the right 
hind paws was measured using a digital touch-free thermometer (Microlife AG, Widnau, Switzerland) at the 
same time points. Of note, these measurements and all subsequent analyses were conducted by two investigators 
blind to the rat cage bedding.
Experimental design. For the induction of CIA rats were randomly assigned into two groups (10 rats per 
group). Five days before immunisation one group of rats was housed in cages with bedding composed of IR Cel-
liant fibres (+IRF rats), while the other group of rats was housed in cages with standard wood shaving bedding 
(−IRF rats). Celliant is produced using a total of 13 naturally occurring, thermoreactive minerals. These include: 
titanium dioxide, a photocatalyst that effectively absorbs light, silicon dioxide, which absorbs and reflects energy, 
and aluminium oxide, which can help increase energy reflectivity. All 13 minerals are ground up into an ultra-
fine powder and then mixed with polyethylene terephthalate to create the ‘Celliant master batch’. Finally, a liquid 
polyester resin is added to the master batch and synthesized into a stable fibre. The cage-bedding was con-
structed from 16 g Celliant (200 g/m2) of 42 mm fibres (thickness less than 10 μ, ceramic loading 1–1.25% by 
weight) and standard wood shavings (1:10 weight/weight) (Fig. S1). According to the manufacturer, the ceram-
ics absorb the body’s heat, transforming it into full-spectrum infrared energy (https ://celli ant.com/how-it-works 
) with a broad-peak cantered at a wavelength of 9.3 µm, whereas the power density depends on the proximity of 
the heat source (living body), but is approximately 0.25 mW/cm2, so for each hour, an energy density of about 
1 J/cm2 is delivered. The standard wood shaving and IR Celliant beddings were changed every second day. The 
burrowing behaviour test was performed on the 21st d.p.i. Following the test animals were anesthetized with an 
intraperitoneal injection of ketamine/xylazine anesthetizing cocktail (80 mg/kg BW ketamine/8 mg/kg BW xyla-
zine) and blood was taken by cardiac puncture. Additionally, from euthanized rats were removed lymph nodes, 
spleens, and hind paws for further analysis.
To examine the effects of rat exposure to IR fibres on CIPI, two sets of experiments (each consisting of two 
separate experiments) were performed. In the first set of experiments, rats were randomly assigned into three 
groups (6 rats per group). Two groups were administered with carrageenan, whereas one group (6 rats) was 
administered with saline (SAL rats). Five days before administration of rat hind paws with carrageenan one 
group of animals was transferred to cages with Celliant bedding (+IRF rats), while the other groups remained in 
cages with standard wooden shaving bedding (−IRF rats). In the second set of experiments, rats were randomly 
assigned into three groups (6 rats per group). Following the administration of right hind paws with carrageenan 
one group of rats was transferred to cages with Celliant bedding (+IRF rats), one group of rats was administered 
with 5 mg/kg Diclofenac (Diklofen, Galenika AD, Belgrade, Serbia) per os (DIC rats), whereas one group of rats 
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remained in cages with standard bedding (−IRF rats). The dose of Diklofen was chosen to correspond to that 
used in  humans41.
In one experiment from each set of experiments 240 min following the carrageenan/saline administration 
burrowing test (lasting for 120 min) was started. At the end of this test, rats were euthanized by an intraperito-
neal injection of ketamine/xylazine anesthetizing cocktail (80 mg/kg BW ketamine/8 mg/kg BW xylazine), and 
their right paws were retrieved for culturing. In the second experiment from each set of experiments, right paw 
volume and mechanical hyperalgesia were examined at one hour intervals over 240 min from the carrageenan/
saline administration.
Paw volume measurement. Paw volume was measured using a plethysmometer (Ugo Basile, Gemonio, 
Lombardy, Italy), as described  previously42. The average of two consecutive volume measurements for each rat 
was used for further calculations. The results are expressed as the difference (dV) between post-immunisation 
or CIPI induction and the basal paw volume according to the following  formula42:
Next, the effect of treatment (Celliant fibres or Diklofen) on dV was calculated according to the following 
formula
* CIA/CIPI rats from cages with standard bedding without any treatment; ** rats exposed to Celliant fibres 
or administered with Diklofen/saline42.
Burrowing training and burrowing test. To assess influence of Celliant bedding on spontaneous joint 
pain, burrowing test, the test developed with the goal of enhancing the translational potential of preclinical 
findings in pain  research43 was used. This test examines burrowing behaviour, an ancient adaptive behaviour 
conserved across many rodent species, one in which various laboratory strains of mice and rats spontaneously 
engage, and, more important, one which is depressed in both mice and rats experiencing inflammatory and 
neuropathic  pain44,45. It is noteworthy, that this behaviour is considered to represent a correlate of so-called 
“activities of daily living” in humans—tasks that are essential to satisfactory quality of life and are often impeded 
by  pain46. For burrowing training and experiments, long plastic tubes (32 cm in length and 10 cm in diameter), 
with the open-end elevated 6 cm from the cage bottom, were filled with 2500 g of gravel (2–6 mm diameter par-
ticles). The training was performed four days before housing in cages with Celliant bedding, and both training 
and burrowing behaviour tests were performed during the dark phase of the daily cycle starting at 6 pm. The 
training was conducted in social facilitation and individual training formats. For social facilitation, the rats from 
one cage were placed in a cage-burrow setup for 120 min. To estimate burrowing behaviour, the weight of the 
burrowed gravel was calculated (weight of gravel left in the tube after completion of burrowing training or test 
was subtracted from the initial weight of gravel in the tube). Individual training was performed so that a single 
rat was placed in a cage-burrow setup for 120 min per day for three consecutive days and the average amount of 
burrowed gravel was determined as explained above. Rats burrowed less than 500 g (four out of 56) were classi-
fied as poor burrowers and they were excluded from further experiments as previously  suggested46. The test was 
performed before immunisation/inflammation induction (to assess basal burrowing activity) and at a certain 
point following the immunisation/inflammation induction.
Following the test burrowing activity (BA) of each rat was calculated according to the following formula:
and then increase in burrowing activity was calculated according to the following formula:
* rats exposed to Celliant fibres or rats administered with Diklofen; **rats from cages with standard bedding.
Electronic Von Frey test. The mechanical hyperalgesia following carrageenan injection was assessed by 
measuring paw withdrawal thresholds (P, expressed in g) using an electronic Von Frey anesthesiometer (IITC 
Life Science, Woodland Hills, CA, United States) as described  previously47,48. The rats were placed in transpar-
ent boxes on the top of a metal grid and allowed to acclimatize for 30 min before testing. A plastic, semi-flexible 
filament coupled with a force transducer was used to deliver the mechanical stimulus. The tip of the filament was 
applied perpendicularly to the plantar surface of the right hind paw and the pressure was gradually increased 
until the rat withdrew its paw (that pressure was recorded automatically on a digital screen). Basal Ps were 
measured before inflammation induction. Basal and post-induction Ps were measured on the right hind paw. 
The results are expressed as the difference (dP) between basal and post-induction Ps according to the following 
 formula47,48:
dV = volume of the inflamed paw (mL) − basal volume of the same paw (mL)
dV reduction (%) =
referent group ∗ average dV − dV of each rat from experimental group ∗ ∗
referent group average dV
×100
BA (%) =
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Treatment reducing dP was recognized as antihyperalgesic treatment. The percentage of the antihyperalgesic 
activity (AHA) was calculated as previously  suggested48:
* rats from cages with standard bedding; ** rats exposed to Celliant fibres or rats administered with Diklofen.
Isolation of mononuclear cells. To obtain mononuclear single cell suspensions from lymph nodes (LNs) 
for the analysis of migratory capacity of innate immune cells in fluorescein isothiocyanate (FITC) painting test 
and spleens for in vitro analyses of adherence and phagocytic capacity of innate immune cells, LNs draining the 
site of FITC application (DLNs) and spleens were dissociated using a 70 µm nylon cell strainer (BD Biosciences, 
Erembodegem, Belgium) and obtained cells were collected in phosphate buffered saline (PBS) supplemented 
with 2% fetal calf serum (FCS, Gibco, Grand Island, NY, USA) and 0.01%  NaN3 (Sigma-Aldrich Chemie GmbH) 
(FACS buffer), respectively. The single cell splenocyte suspensions were subjected to  NH4Cl lysis to remove red 
blood cells and then washed in ice-cold FACS buffer. The mononuclear single cell suspensions from DLNs and 
spleen of each animal were enumerated using an improved Neubauer hemacytometer and trypan blue dye to 
exclude non-viable cells and adjusted to 1 × 107 cells/mL.
Flow cytometry analysis (FCA). Briefly, for FCA single cell suspensions from DLNs and spleen were 
subjected to direct or indirect immunolabeling as previously described in  details49. After immunolabeling 50,000 
cell events per sample were acquired on a FACSCalibur flow cytometer (Becton–Dickinson, Mountain View, CA, 
USA). Data were analysed using FlowJo software version 7.8. (TreeStar Inc, Ashland, OR, USA). Dead cells and 
debris were excluded from the analyses by selective gating based on forward scatter (FSC) and side scatter (SSC).
Innate immune cell functional assays. To assess the migration capacity of innate immune cells FITC 
painting test was  used50. Briefly, rat left flank was shaved and painted with 300 μL of 5 mg/mL FITC dissolved 
in equal volumes of acetone and dibutylphthalate. After 24 h, ipsilateral (the side subjected to FITC painting) 
inguinal and axillary DLNs were extirpated and divided into two portions. From one portion single mononu-
clear cell suspensions were prepared as described above, whereas another portion was used to examine CCL19 
and CCL21 expression using Reverse Transcription-Quantitative Polymerase Chain Reaction. Aliquots of 100 
µL of DLN suspensions were processed for indirect immunolabeling with biotin-conjugated anti-CD11b and 
PerCP-conjugated streptavidin as primary and second step reagent, respectively. Following washing, cells were 
acquired for analysis using a FACSCalibur flow cytometer as described above. Results were expressed as % of 
FITC + cells within the CD11b + LN cells.
Innate immunity cells isolated from spleen were tested for cell adherence ability using a modification of 
previously described  method51. Aliquots of 500 µL of splenocyte suspension (1 × 106 cells/ml) were placed in 
an adherence column consisting of a 1 mL syringe packed with 50 mg of nylon fibres to a height of 1.25 cm. 
After 10 min, the effluent containing the non-adherent cells was drained by gravity. Initial cell suspensions and 
effluents were processed for immunolabeling with FITC-conjugated anti-CD11b (clone ED8; Serotec, Oxford, 
UK) antibody. The cells were incubated with saturating concentrations of the fluorochrome-labeled antibody for 
30 min, washed with FACS buffer, and subsequently subjected for FCA. Results were expressed as
To assess the phagocytic capacity of innate immune cells a previously described method was  used49. Briefly, 
100 µl aliquots of splenocyte suspensions (1 × 106 cells/ml) described, were incubated with sonicated (2 min at 
room temperature) 1 µm sized yellow-green fluorescent carboxylated polystyrene latex beads (Sigma-Aldrich 
Chemie GmbH) in complete RPMI-1640 culture medium supplemented with 5% FCS (bead:cell ratio of 50:1) 
for 1 h at 37 ºC. To arrest phagocytosis, the cells were placed on ice for 5–10 min. Following this step, cells were 
washed with ice cold PBS and incubated with biotin-conjugated anti-CD11b (BD Biosciences, Mountain View, 
CA, USA) antibody for 30 min at 4 ºC and then again washed with FACS buffer. In the next step, cells were 
incubated with PerCP-conjugated streptavidin (BD Biosciences) as the second step reagent for another 30 min, 
washed with FACS buffer and acquired for analysis using a FACSCalibur flow cytometer. Cells incubated with 
the latex beads at 4 ºC were used to set up the positive/negative cut-off for Latex + cells in FCA. Results were 
expressed as % of Latex + cells within the CD11b + cell population.
Reverse transcription‑quantitative polymerase chain reaction. Total RNA was extracted by 
the ABI Prism 6100 Nucleic Acid PrepStation system (Applied Biosystems, Foster City, CA, USA) using the 
total RNA Chemistry Starter Kit (Applied Biosystems) and DNAse wash solution (Absolute RNA Wash Solu-
tion; Applied Biosystems). cDNA was synthesized using the High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems). Triplicate 25-μL RT-qPCR reactions were performed using the TaqMan Gene Expression 
Master Mix (Applied Biosystems) and premade TaqMan Gene Expression Assays (Applied Biosystems) under 
the default Applied Biosystems 7500 Real-Time PCR System conditions. All the procedures were described in 
 detail52. The following TaqMan Gene Expression Assays were used: CCL19 (Ccl19, Rn01439563_m1), CCL21 
(Ccl21, Rn01764651_g1), and β-actin (Actb, Rn00667869_m1). Target mRNA expression was determined using 
the comparative threshold cycle (dCt) method with β-actin as a reference and SDS v1.4.0. software (Applied 
AHA (%) =
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Biosystems). Relative amounts of target mRNAs were shown as  2–dCt values, representing the ratio of target to 
reference genes, where dCt = Ct target – Ct reference.
Anti‑CII antibody ELISA. Serum samples were obtained by centrifugation of blood at 2000g for 15 min at 
4 °C. Aliquots of sera were de-complemented (56 °C, 30 min) and stored at -20 °C until analysis. The serum level 
of CII-specific antibodies was assayed by ELISA in 96-well plates (MaxiSorp, Nunc). The plates were coated (50 
μL/well) with 5 μg/mL of CII in 50 mM carbonate buffer (pH 9.6) by overnight adsorption at + 4 °C and then 
incubated with 2% bovine serum albumin (BSA) in PBS (100 μL/well) for 1 h at room temperature. Serum sam-
ples were added to the plate (50 μL/well) in duplicate and incubated overnight at + 4 °C. The biotin-conjugated 
anti-IgG antibody was added to the plate (50 μL/well) and incubated 1 h at room temperature followed by 1 h 
incubation with a streptavidin–horseradish peroxidase. At each step, the plate was washed with 0.05% Tween 
20/PBS (4 × 200 μL/well). Antigen–antibody interactions were visualized using the extrAvidin-peroxidase/o-
phenylenediamine system (Sigma, Steinheim, Germany). Dilutions of sera (1: 100), biotin-conjugated anti-IgG 
antibody (1: 1000; Biolegend Inc., San Diego, CA, USA) and extrAvidin-peroxidase (1: 3000) were prepared in 
2% BSA/PBS. The reaction was stopped by the addition of 1 M  H2SO4 (50 μL/well) and absorbance was read 
at 492/620 nm  (A492/620). The cutoff value was defined according to the  A492/620 value obtained from “negative 
control” wells (2% BSA/PBS) plus 3 × Standard Deviation. Samples were considered positive when the  A492/620 
value exceeded the cut off value.
Paw tissue culture. Inflamed paws collected by incising at the fur line. Paws from CIA rats were weighed, 
carefully cut into small pieces and cultured in RPMI 1640 medium (Sigma-Aldrich Chemie GmbH) supple-
mented with 2 mM l-glutamine (Serva, Heidelberg, Germany), 1 mM Na pyruvate (Serva), 100 U/mL peni-
cillin (ICN, Costa Mesa. CA, USA), 100 μg/mL streptomycin (ICN) and 10% fetal bovine serum, at 37 °C, in 
a humidified air atmosphere of 5% v/v CO2, for 4 h (for  PGE2 assay) or overnight (for analyses of NO and 
cytokine production levels, and redox status parameters), as previously  described28,29,53. Following extirpation of 
carrageenan-inflamed paws, soft paw tissues were carefully removed, weighed, cut into small pieces and cultured 
as described above.
PGE2, cytokine and NO production. Paw tissue culture supernatants were examined for inflamma-
tory/pain mediators using the following commercial ELISA kits: IL-17A (BioLegend, San Diego, CA, USA), 
IL-1β (Thermo Scientific, Pierce Biotechnology, Rockford, IL, USA), PGE2, IL-10 and TGF-β (R&D Systems, 
Minneapolis, MN, USA), according to the manufacturer’s instructions. Standard curve was calculated for each 
assay with limits of detection for IL-17 = 8  pg/ml, IL-1β = 6.5  pg/mL, TNF-α = 2  pg/mL, IL-10 < 10  pg/mL, 
TGF-β = 4.6 pg/mL and PGE2 < 39 pg/mL. Cytokines and PGE2 concentrations were normalized to paw weight.
The concentration of nitrite, as the end-product of NO production, was measured in the paw tissue culture 
supernatants using a method based on the Griess  reaction54. The nitrite concentration was calculated using a 
 NaNO2 standard curve with a range from 1 to 40 μM and normalized to paw weight.
Assessment of redox status parameters. The parameters of redox status were measured in sera and 
inflamed paw cultures. The levels of superoxide anion radical  (O2• ‾) were estimated from the rate of reduction 
of nitroblue tetrazolium (NBT) as described by Auclair and  Voisin55. Results were expressed as μM of reduced 
NBT/min/L.
Total oxidant capacity (TOC) was determined by a modified spectrophotometric method using o-dian-
isidinine56,57. The assay was calibrated with hydrogen peroxide (aqueous solution, concentration range 
10–200 mmol/L) and the results were expressed in µmol/L hydrogen peroxide per liter (mmol  H2O2 eq./L).
Cu/Zn superoxide dismutase (SOD) activity was determined by a modified spectrophotometric method 
based on the ability of the SOD enzyme to inhibit the autoxidation of epinephrine in an alkaline medium or 
bicarbonate buffer 0.05 mmol/L pH 10.258. The SOD activity was calculated as the percentage inhibition of 
epinephrine autooxidation.
The level of SH-groups (SHG) was determined by Ellman’s  method59 using 10 mM DTNB (dinitrodith-
iobenzoic acid) as a reagent. DTNB reacts with aliphatic thiol compounds in the base medium (pH 9.0) and this 
reaction generates 1 mol of p-nitrophenol anion per mole of thiol. Calibration of the method was achieved using 
reduced glutathione in the concentration range from 0.1 to 1.0 mM.
Pro-oxidative-antioxidant balance (PAB) was determined by a modified PAB assay using 0.6% 3.3 ’, 5,5′-tetra-
methylbenzidine (TMB) in dimethyl sulfoxide (DMSO) as a  chromogen60. The PAB test measures the concen-
tration of  H2O2 in an antioxidant environment, as TMB can react at the same time with  H2O2 (a peroxidase-
catalyzed reaction) as well as with reducing substances such as uric acid (chemical, non-catalyzed reaction). The 
enzymatic reaction leads to the oxidation of TMB to a blue product and its reduction to a non-colored product. 
The net reaction is the difference between the two opposite oxidative and reductive processes on the same sub-
strate. The reaction is calibrated with a mixture of  H2O2 and uric acid at different ratios, ranging from 0 to 100%.
All analyses were performed on ILAB 300 Plus analyzer (Instrumentation Laboratory, Milan, Italy) except 
the PAB, which was measured on the Spectro star Nano ELISA reader (BMG Labtech, Ortenberg, Germany).
Statistical analysis. All statistical analyses were performed using GraphPad Prism Version 7 (GraphPad 
Software, Inc., La Jolla, CA, USA) and SigmaPlot 11 (Systat Software Inc., Richmond, CA) softwares. Data are 
expressed as mean ± SEM. Differences between groups were tested by Student’s unpaired t-test, except differ-
ences in paw volume, temperature, and hyperalgesia in carrageenan-induced paw inflammation that were ana-
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lysed by two-way repeated measures ANOVA followed by Bonferroni test for post hoc comparisons. Values of 
p ≤ 0.05 were considered significant.
Results
Modulatory effects of IR fibres on the autoimmune response, inflammation and burrowing 
behaviour of CIA‑affected rats. CIA‑affected rats from cages with IR fibre bedding exhibit better burrowing 
performance compared with their counterparts from cages with standard bedding. Generally, the kinetics of CIA 
development in rats housed in cages with standard bedding followed that described in our previous  studies27,28 
(Fig. S2). In rats housed in cages with IR fibre bedding, the onset of the disease was slightly postponed (from the 
13th to the 15th d.p.i. compared with −IRF controls (Fig. 1A). The analysis of the differences in the daily arthritic 
score using repeated measures two-way ANOVA showed a clear tendency to significance (p = 0.051) in the re-
duction of the clinical severity of the disease in rats exposed to IR fibres compared with their −IRF counterparts 
(Fig. 1A). Additionally, the cumulative score of the disease (the sum of daily clinical scores of each individual rat 
during the observation period) was lower (p ≤ 0.05) in +IRF rats (72.1 ± 9.70) when compared with −IRF ones 
(47.4 ± 5.56). Rats were also examined for the volumes of inflamed hind paws. In all CIA-affected rats the vol-
umes of hind paws were increased (Fig. 1A). This increase was less (p ≤ 0.01) pronounced in +IRF rats compared 
with their −IRF counterparts, indicating that the exposure to infrared radiation from IR fibre bedding efficiently 
reduces the inflammation-induced increase in paw volume (Fig. 1A).
Furthermore, rats were examined for burrowing behaviour. Rats housed in cages with IRF bedding showed 
better (p ≤ 0.05) burrowing performance compared with −IRF rats (Fig. 1B, Fig. S3).
Lower serum levels of serum CII‑specific IgG antibodies in CIA‑affected rats from cages with IR fibre bedding and 
diminished IL‑17 production in cultures of their hind paws. Given that (i) arthritogenic anti-CII antibodies are 
essential for the development of  CIA61,62 and (ii) particularly that the arthritogenic antibodies (including those 
specific for CII) are shown to cause pain even in the absence of overt signs of  inflammation38,63, serum levels 
of CII-specific IgG antibodies in CIA rats were examined. Their levels were lower (p ≤ 0.01) in sera from rats 
Figure 1.  Influence of exposure to IR fibres on daily arthritis score, paw edema and burrowing behaviour in 
CIA-affected rats. (A) Line graph shows daily arthritis score from the 12th–22nd day post-immunisation (d.p.i.) 
in CIA rats housed in cages with IR-fibre bedding (+IRF rats) or in cages with standard wooden shaving bedding 
(−IRF rats). Of note, rats were transferred to cages with IR fibre bedding five days before immunization. Scatter 
plot indicates CIA-induced increase in hind paw volume (dV) in +IRF and −IRF rats. Bar graph shows the dV 
reduction (%) in +IRF rats relative to −IRF rats (see Material and Methods). Photographs show representative 
arthritic front and hind paw joints from rat with CIA. (B) Scatter plot indicates the burrowing activity (BA) of 
each +IRF and −IRF rat expressed as the percentage of the BA before immunisation (basal activity). Bar graph 
shows the increase in BA (%) in +IRF rats relative to −IRF rats (see Material and Methods). All graphs were 
created using GraphPad Prism version 7.00 for Windows, GraphPad Software, La Jolla, California, USA (https 
://www.graph pad.com). Photograph shows a cage-burrow setup and burrowed gravel. Results are expressed as 
mean ± SEM. n = 10 rats/group. * p ≤ 0.05 and ** p ≤ 0.01.
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transferred to cages with IR fibres bedding (five days before CIPI induction) compared with their counterparts 
housed into cages with standard bedding (Fig. 2A).
Considering the crucial role of Th17 cells in driving joint damage and consecutive  inflammation64, the pro-
duction levels of IL-17, Th17 cell signature cytokine, were examined in supernatants of inflamed paw tissue 
cultures. The production levels of this cytokine were lower (p ≤ 0.05) in supernatants of inflamed paw tissue 
cultures from +IRF rats compared with −IRF ones (Fig. 2B).
Impaired migration, but greater phagocytic capacity of innate immune CD11b + cells from CIA‑affected rats exposed 
to IR fibres. Considering the role of innate immune CD11b + cells in the development of joint impairment and 
inflammation in  CIA65, and the significance of their infiltration into inflamed joint tissue, migratory, adherence 
and phagocytic capacity of CD11b + cells from CIA rats housed in cages with IR fibre and standard bedding were 
examined.
The analysis of the frequency of FITC-labelled CD11b + cells in DLNs in the FITC painting test revealed that 
their frequency was lower (p ≤ 0.01) in +IRF rats than in −IRF controls, indicating impaired migration capacity 
of CD11b + cells in rats from cages with IR fibre bedding (Fig. 3A). Considering that CD11b cells express CCR7 
receptor so that their trafficking is substantially influenced by CCL19 and CCL21  chemokines50,66, the expres-
sion of mRNAs for these chemokines in DLNs was examined, as well. Indeed, the exposure to IR cage bedding 
reduced (p ≤ 0.01) the expression of mRNAs for both chemokines (Fig. 3A).
Next, considered that in the response to tissue inflammation CD11b + cells leave the spleen en masse to accu-
mulate in injured tissue, and participate in the control of inflammation by phagocyting dead cells and necrotic 
tissue, and secreting anti-inflammatory/immunoregulatory  mediators67,68, the adherence and phagocytic capacity 
of CD11b + cells from spleen were examined. We failed to show any statistically significant difference between 
the adherence capacity of CD11b + splenocytes from +IRF rats and those from −IRF rats (Fig. 3B). The analysis 
of Latex bead phagocytosis showed higher (p ≤ 0.001) phagocytic capacity of CD11b + splenocytes from rats 
exposed to IR fibres had compared with those from rats housed in cages with standard bedding (Fig. 4).
Exposure of CIA‑affected rats to IR fibres decreases the production levels of pro‑inflammatory mediators, but 
increases production levels of anti‑inflammatory/immunoregulatory mediators in cultures of inflamed paws. To 
elucidate molecular mechanisms underlying less prominent paw swelling and better burrowing performance 
of +IRF rats, the production of the key pro-inflammatory mediators with algogenic properties  (PGE2, NO, 
TNF-α and IL-1β)69,70 and anti-inflammatory/immunoregulatory mediators with analgesic properties (IL-10 
and TGF-β)71,72 was examined in cultures of their hind paws.
Figure 2.  Influence of exposure to IR fibres on the level of CII-specific IgG antibodies in sera and the 
production of IL-17 in inflamed paws from CIA-affected rats. (A) Scatter plot indicates the level of anti-CII IgG 
antibodies  (OD492nm × 1000) in sera from CIA rats housed in cages with IR fibres bedding (+IRF rats) and with 
standard wooden shaving bedding (−IRF rats). Of note, rats were transferred to cages with IR fibre bedding 
five days before immunization. (B) Scatter plot shows IL-17 production level in the supernatants from hind 
paw tissue cultures (normalized to the paw weight) from +IRF and −IRF rats. Scatter plots were created using 
GraphPad Prism version 7.00 for Windows, GraphPad Software, La Jolla, California,USA (https ://www.graph 
pad.com). Results are expressed as mean ± SEM. n = 10 rats/group. * p ≤ 0.05 and ** p ≤ 0.01.
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The production levels of  PGE2, a pro-inflammatory lipid mediator present at high levels in the synovial fluid 
of patients suffering from  RA73–75, were lower (p ≤ 0.01) in paw cultures from +IRF rats when compared with 
those from −IRF rats (Fig. 5).
Additionally, production levels of NO, the pro-inflammatory mediator with an important role in the develop-
ment of joint injury and  inflammation76, were also lower (p ≤ 0.01) in inflamed paw cultures from rats exposed 
to IR-emitting fibres than in those from rats housed in cages with standard bedding (Fig. 5).
On the other hand, we failed to show statistically significant differences in the production levels of pro-
inflammatory cytokines (TNF-α and IL-1β), which are shown to significantly contribute to the joint injury and 
inflammation, and consequently arthralgia in  RA77 in inflamed paw tissue cultures from +IRF rats and their −IRF 
counterparts (Fig. 5).
Considering that the ratio between pro-inflammatory to anti-inflammatory/immunoregulatory mediators 
(IL-10 and TGF-β) in inflamed tissue is more important for RA severity than their absolute  levels37 and that both 
IL-10 and TGF-β act as endogenous  analgesics71,72, their production levels in hind paw cultures were explored, 
as well. The levels of IL-10 and TGF-β were higher (p ≤ 0.05 and p ≤ 0.001, respectively) in cultures of inflamed 
paws from +IRF rats compared with IRF rats (Fig. 5).
CIA‑affected rats from cages with IR fibres exhibit improved serum redox status compared with their counterparts 
from cages with standard bedding. Given that oxidative stress has been also implicated in the development of 
inflammation in chronic autoimmune diseases, including RA and its experimental  models78, the redox status 
was examined in both sera and inflamed joint tissue cultures.
Figure 3.  Influence of exposure to IR fibres on the migration and adherence capacity of innate immune 
CD11b + cells from CIA-affected rats. (A) Representative flow cytometry dot plots show the frequency of FITC-
stained CD11b + cells in lymph nodes draining the site of FITC application (DLN) in FITC painting test (see 
Material and Methods) in CIA rats housed in cages with IR fibre bedding (+IRF rats) and with wooden shaving 
bedding (−IRF rats). Of note, rats were transferred to cages with IR fibre bedding five days before immunization. 
Bar graphs show the expression of mRNA for CCL19 and CCL21 in DLNs from +IRF and −IRF rats, as 
determined by RT-qPCR. Results are represented as  2−dCt relative to β-actin. (B) Representative flow cytometry 
dot plots show CD11b expression on splenocytes from +IRF and −IRF rats before (upper dot plots) and after 
(lower dot plots) passage through nylon wool in the adherence assay (see Material and Methods). Scatter plot 
indicates the adherence index, i.e. the percentage of adherent cells of CD11b + cells from spleens of +IRF and −
IRF rats (calculated as indicated in Material and Methods). (A, B) Flow cytometry profiles were generated using 
FlowJo Software for Windows, Version 7.8. FlowJo, LLC, Ashland, Oregon, USA (https ://www.flowj o.com). 
Bar graphs (A) and (B) scatter plot were created using GraphPad Prism version 7.00 for Windows, GraphPad 
Software, La Jolla California, USA (https ://www.graph pad.com). Results are expressed as mean ± SEM. n = 10 
rats/group. ** p ≤ 0.01.
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The exposure of rats to IR-emitting fibres had no effects on the serum level of  O2• 
− and SOD activity in CIA 
rats (Fig. 6). However, lower (p ≤ 0.05) TOC levels accompanied by higher SHG (p ≤ 0.001) levels were found in 
sera from +IRF rats compared with control rats (Fig. 6). Consistently, lower (p ≤ 0.05) PAB value was detected 
in sera from +IRF rats compared with −IRF rats (Fig. 6).
We failed to detect any statistically significant differences in the examined redox parameters in the inflamed 
paw cultures (Fig. S4).
Housing of rats in cages with IF fibre bedding beginning 5 days before carrageenan adminis‑
tration moderates CIPI development. Given that rats from cages with IR bedding exhibited dimin-
ished antibody and Th17 cell responses, and that anti-CII antibodies are found to induce pain behaviour acting 
directly on sensory neurons, viz. independently of their pro-inflammatory action as pathological  antibodies38, 
the study was extended to encompass CIPI model, a “classical” model of the non-autoimmune inflammatory 
response and inflammatory pain.
Exposure to IR fibres reduces temperature, swelling and hyperalgesia of carrageenan‑inflamed rat paws and 
improves burrowing behaviour of CIPI‑affected rats. In rats housed in the cages with IR fibre bedding the sur-
face temperature of carrageenan-injected inflamed paw was lower than in rats housed with standard bedding 
at 120 min (p ≤ 0.05), 180 min (p ≤ 0.001) and 240 min (p ≤ 0.05) after the injection of carrageenan (Fig. 7). The 
surface temperature of paws injected with saline did not change during the period of observation, and it was 
lower when compared with the surface temperature of carrageenan-injected paws from −IRF rats at 120 min 
(p ≤ 0.05), 180 min (p ≤ 0.001) and 240 min (p ≤ 0.001) post-injection (Fig. 7). Besides, it was lower when com-
pared with the surface temperature of carrageenan-injected paws from +IRF rats at 180  min (p ≤ 0.05) post-
injection (Fig. 7). Additionally, in rats housed in the cages with standard bedding, the intraplantar injection 
of carrageenan elicited paw swelling, as one of the cardinal signs of inflammation (Fig. 8A). In −IRF rats this 
increase in paw volume was at the maximum at 180 min post injection of carrageenan and remained at this level 
until the end of observation (Fig. 8A). In the rats transferred to cages with IR fibre bedding five days before the 
administration of carrageenan, the paw volume gradually increased until 240 min post the injection of carra-
geenan (Fig. 8A). Control SAL rats exhibited a transient increase in the affected paw volume 60 min after injec-
tion of saline, but even at this increase was lower (p ≤ 0.05) than in carrageenan-injected −IRF rats (Fig. 8A). In 
rats exposed to IRF as cage bedding, the increase in the volume of the carrageenan-administered paw was lower 
(p ≤ 0.05) at 60 min after the injection than in −IRF rats, and it remained lower (p ≤ 0.001) when examined at 
later time points (Fig. 8A).
The analysis of burrowing performance showed that carrageenan markedly impaired (p ≤ 0.01) burrowing 
activity of both −IRF and +IRF rats compared with SAL control rats (Fig. 8B, Fig. S5). However, this carrageenan-
induced decrease in burrowing performance was less (p ≤ 0.05) prominent in +IRF rats compared with their −IRF 
counterparts (Fig. 8B, Fig. S5), indicating that infrared radiation from IRF cage bedding ameliorates burrowing 
performance of CIPI rats (Fig. 8B, Fig. S5).
Figure 4.  Influence of exposure to IR fibres on the phagocytic capacity of innate immune CD11b + cells from 
CIA-affected rats. Representative flow cytometry histograms show latex particle phagocytosis at + 4° C and + 37° 
C by CD11b + cells (gated as shown in representative flow cytometry dot plots generated using FlowJo Software 
for Windows, Version 7.8. FlowJo, LLC, Ashland, Oregon, USA; https ://www.flowj o.com.) from CIA rats housed 
in cages with IR fibre bedding (+IRF rats) and with standard wooden shaving bedding ( –IRF rats). Rats were 
transferred to cages with IR fibre bedding five days before immunization. Note that a significant difference 
between the groups was apparent only at 37° C. Scatter plot (created using GraphPad Prism version 7.00 for 
Windows, GraphPad Software, La Jolla, California, USA; https ://www.graph pad.com) indicates the percentage 
of phagocyting (latex +) cells among CD11b + cells from the spleen of +IRF and –IRF rats (see Material and 
Methods). Results are expressed as mean ± SEM. n = 10 rats/group. *** p ≤ 0.001.
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Considering that differently from chronic pain conditions, in acute pain models reliability of tests evaluating 
spontaneous behaviours or activities of rodents in their home environments, as it is burrowing test, have not been 
systematically  evaluated79, pain behaviour in CIPI model was also examined using classic mechanical stimulus-
evoked von Frey test (Fig. 8C). Using this test we found that, compared with the administration of saline, the 
administration of carrageenan produced paw hyperalgesia (p ≤ 0.001) at all examined time points (Fig. 8C). 
Additionally, at all examined time points following carrageenan administration rats housed in cages with IR fibre 
bedding developed markedly less prominent (p ≤ 0.001) paw hyperalgesia compared with rats housed in cages 
with standard bedding (Fig. 8C). The analysis of infrared radiation efficacy showed that its anti-hyperalgesic 
efficacy decreased from 180 min onwards (Fig. 8C).
Exposure to IR fibres diminishes production of proinflammatory mediators, but increases production of anti‑inflam‑
matory mediators in cultures of carrageenan‑inflamed paws. The production of  PGE2 and NO, pro-inflamma-
tory mediators implicated in the development of  CIPI80, was examined in the cultures of carrageenan-inflamed 
paws. The production levels of  PGE2 were reduced (p ≤ 0.05) in cultures of inflamed paw tissues from +IRF rats 
compared with their −IRF counterparts (Fig. 9). On the other hand, the production levels of NO were compara-
ble in inflamed paw tissue cultures from +IRF rats and −IRF ones (Fig. 9).
Considering the significant role of TNF-α and IL-1β in development CIPI and related  allodynia81,82, their 
production levels in cultures of inflamed paws were also examined. The production of IL-1β by inflamed paw tis-
sues from +IRF rats was lower (p ≤ 0.01) when compared with its production by inflamed paw tissues from −IRF 
Figure 5.  Influence of exposure to IR fibres on the production of  PGE2, NO and cytokines by inflamed paws 
from CIA-affected rats. Scatter plots (created using GraphPad Prism version 7.00 for Windows, GraphPad 
Software, La Jolla, California, USA; https ://www.graph pad.com) show  PGE2, NO, TNF-α, IL-1β, TGF-β 
and IL-10 production levels in the supernatants from 4 h (PGE2) and overnight hind paw tissue cultures 
(normalized to the paw weight) (see “Material and methods”) from CIA rats were housed in cages with IR fibre 
bedding (+IRF) and their counterparts housed in cages with standard wooden shaving bedding (−IRF rats). Rats 
were transferred to cages with IR fibre bedding five days before immunization. Hind paws were excised from 
CIA rats on the 22nd day post immunisation. Results are expressed as mean ± SEM. n = 10 rats/group. * p ≤ 0.05, 
** p ≤ 0.01 and *** p ≤ 0.001.
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rats (Fig. 9). Differently, the production levels of TNF-α in inflamed paw tissue cultures from +IRF rats did not 
statistically significantly differ from those in inflamed paw cultures from −IRF rats (Fig. 9).
On the other hand, the production levels of TGF-β were higher (p ≤ 0.01) in cultures of inflamed paw tissues 
from +IRF rats compared with those from −IRF ones, whereas those of IL-10 were comparable between these 
cultures (Fig. 9).
Figure 6.  Influence of exposure to IR fibres on the redox status in sera from CIA-affected rats. Scatter plots 
show pro-oxidant parameters: superoxide anion radical (O2• −) level and total oxidant capacity (TOC); 
antioxidant parameters: superoxide dismutase (SOD) activity, and sulfhydryl groups (SHG) level; and pro-
oxidant-antioxidant balance (PAB) in sera from CIA rats housed in cages with IR fibre bedding (+IRF) and their 
counterparts housed in cages with standard wooden shaving bedding (−IRF rats). Of note, rats were transferred 
to cages with IR fibre bedding five days before immunization. Sera were obtained from CIA rats on the  22nd 
day post immunisation. All graphs were created using GraphPad Prism version 7.00 for Windows, GraphPad 
Software, La Jolla, California, USA (https ://www.graph pad.com). Results are expressed as mean ± SEM. n = 10 
rats/group. * p ≤ 0.05 and *** p ≤ 0.001.
Figure 7.  Influence of exposure to IR fibre bedding on the paw temperature of rats with carrageenan-inflamed 
paws. Rats housed in cages with IR fibre bedding (+IRF) or in cages with standard wooden shaving bedding 
(−IRF) were injected with carrageenan. Of note, rats were transferred to cages with IR fibre bedding five days 
before immunization. Rats housed in the cages with standard wooden shaving bedding were injected with 
saline to serve as an additional control (SAL rats). Line graph (created using GraphPad Prism version 7.00 for 
Windows, GraphPad Software, La Jolla California USA; https ://www.graph pad.com) indicates the surface paw 
temperature measured before and after carrageenan or saline injection in +IRF, –IRF and SAL rats. Of note, 
rats were transferred to cages with IR fibre bedding five days before immunization. Results are expressed as 
mean ± SEM. n = 6 rats/group.* p ≤ 0.05 and *** p ≤ 0.001 vs –IRF; and # p ≤ 0.05 vs +IRF.
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Figure 8.  Influence of exposure to IR fibre bedding on paw edema, mechanical stimulus-evoked pain 
behaviour, and burrowing behaviours of rats with carrageenan-inflamed paws. Right hind paws of rats housed 
in cages with IR fibre bedding (+IRF) or in cages with standard wooden shaving bedding (−IRF) were injected 
with carrageenan. Of note, rats were transferred to cages with IR fibre bedding 5 days before immunization. 
A group of rats with right hind paws injected with saline from cages with standard wooden shaving bedding 
served as an additional control (SAL rats). (A) Line graph indicates the increase in paw volume (dV) in 
carrageenan or saline administered rats relative to that before the administration. Bar graph shows the dV 
reduction (%) in +IRF rats relative to −IRF rats (see “Material and methods”). (B) Scatter plot indicates the 
burrowing activity (BA) of each rat following carrageenan or saline administration expressed as the percentage 
of the BA before the administration (basal activity). Bar graph shows the increase in BA (%) in +IRF rats relative 
to −IRF rats (see “Material and methods”). (C) Line graph indicates the difference between the paw withdrawal 
thresholds after and before carrageenan or saline injection (dP) in +IRF, –IRF and SAL rats. Bar graph shows 
the antihyperalgesic activity (AHA) of exposure to IR fibre bedding (+IRF) in rats with carrageenan-induced 
paw inflammation (see “Material and methods”). All line graphs and scatter plots were created using GraphPad 
Prism version 7.00 for Windows, GraphPad Software, La Jolla, California, USA (https ://www.graph pad.com). 
Results are expressed as mean ± SEM. n = 6 rats/group.* p ≤ 0.05 and *** p ≤ 0.001 vs −IRF; and ## p ≤ 0.01 ### 
p ≤ 0.001 vs +IRF.
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Effects of the exposure of rats affected with CIPI to IRF fibres as cage bedding in the treat‑
ment paradigm. Exposure to IR fibres in the treatment paradigm reduces swelling and hyperalgesia of car‑
rageenan‑inflamed rat paws and improves burrowing behaviour of CIPI‑affected rats. As described above, the 
carrageenan-injected paws from rats housed in the cages with standard bedding showed the increase in the 
volume at the examined time points, but at 180 min following the administration of carrageenan, this increase 
reached a plateau (Fig. 10A). At 120 min following the administration of carrageenan (p ≤ 0.01) and at all the lat-
ter examined time points this increase was less (p ≤ 0.05) prominent in rats transferred to cages with IR bedding 
following carrageenan administration compared with their counterparts housed in cages with standard bedding 
(Fig. 10A). Similarly, Diklofen reduced (p ≤ 0.001) the increase in the volume of inflamed paw at all time points 
from 120 min onwards (Fig. 10A). Comparing the effects of IR fibres and Diklofen on the increase in the volume 
of inflamed paws, we found that this analgesic drug was more (p ≤ 0.001) efficient than infrared radiation at 
120 min (p ≤ 0.001) and 240 min (p ≤ 0.001) following carrageenan administration (Fig. 10A).
The exposure of rats to infrared radiation from cage bedding increased (p ≤ 0.001) their burrowing perfor-
mance, but to a lower extent (p ≤ 0.05) than the administration of Diklofen (Fig. 10B, Fig. S6). Accordingly, 
the subsequent analysis of infrared radiation efficacy showed that this treatment was less (p ≤ 0.01) efficient in 
increasing rat burrowing performance than Diklofen administration (Fig. 10B, Fig. S6).
As expected from the previous experiment, carrageenan increased paw hyperalgesia at all examined time 
points following carrageenan administration (Fig. 10C). The exposure to IR fibres reduced hyperalgesia (p ≤ 0.01) 
at 120 min and at all examined time points onward (Fig. 10C). Differently, Diklofen decreased (p ≤ 0.001) hyper-
algesia at all examined time points (Fig. 10C). Compared with Diklofen infrared radiation from the cage bedding 
Figure 9.  Influence of exposure to IR fibre bedding on the production of PGE2, NO, and cytokines by 
carrageenan-inflamed paws. Scatter plots (created using GraphPad Prism version 7.00 for Windows, GraphPad 
Software, La Jolla California USA; https ://www.graph pad.com) show PGE2, NO, TNF-α, IL-1β, TGF-β and 
IL-10 production levels in the supernatants from 4 h (PGE2) or overnight right carrageenan-inflamed hind 
paw tissue cultures (normalized to the paw weight) (see Material and Methods) from rats housed in cages 
with IR fibre bedding (+IRF) and with standard wooden shaving bedding (−IRF rats). Results are expressed as 
mean ± SEM. n = 6 rats/group. * p ≤ 0.05 and ** p ≤ 0.01.
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was less efficient (p ≤ 0.001) in this respect at all examined time points (Fig. 10C). The analysis of Diklofen and 
infrared fibres anti-hyperalgesic efficacy showed that Diklofen was more efficient at 120 min, 180 min, and 
240 min that the exposure to IR fibres, whereas their efficacy was comparable at 60 min (Fig. 10C).
Exposure to IR fibres in treatment paradigm diminishes production of proinflammatory mediators, but increases 
production of anti‑inflammatory mediators in cultures of carrageenan‑inflamed paws. In accordance with the 
effects of IRF on paw inflammation, the production levels of PGE2 and NO were diminished (p ≤ 0.001) in 
cultures of inflamed paw tissues from rats exposed to IRF as cage bedding in immediacy following e treatment 
Figure 10.  Influence therapeutic exposure to IR fibre on paw edema, mechanical stimulus-evoked pain 
behaviours and burrowing behaviour of rats with carrageenan-inflamed paws. Immediately after their right hind 
paws were injected with carrageenan rats were transferred in cages with IR fibre bedding (+IRF rats) or left in 
standard wooden shaving bedding (−IRF rats). Right paws from a randomly chosen group of −IRF rats were 
administered with 5 mg/kg Diklofen per os (DIC rats). (A) Line graph indicates the increase in paw volume 
after carrageenan injection (dV) in respect to that before the administration of carrageenan. Bar graph shows 
the dV reduction (%) in +IRF and DIC rats relative to −IRF rats (see “Material and methods”). (B) Scatter plot 
indicates the burrowing activity (BA) after carrageenan injection in +IRF, −IRF and DIC rats. Bar graph shows 
the increase in BA (%) in +IRF and DIC rats relative to −IRF rats (see “Material and methods”). (C) Line graph 
indicates the difference between the paw withdrawal thresholds after and before carrageenan injection (dP) 
in +IRF, –IRF and DIC rats. A bar graph shows the antihyperalgesic activity (AHA) of exposure to IR fibre 
bedding in a treatment paradigm (+IRF) and Diclofenac treatment (DIC) in rats with carrageenan-induced paw 
inflammation (see Material and Methods). All line graphs and bar graphs were created using GraphPad Prism 
version 7.00 for Windows, GraphPad Software, La Jolla, California, USA (https ://www.graph pad.com). Results 
are expressed as mean ± SEM. n = 6 rats/group.* p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 vs −IRF; and # p ≤ 0.05, ## 
p ≤ 0.01 and ### p ≤ 0.001 vs +IRF.
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carrageenan administration when compared with those from inflamed paw tissues from rats left in cages with 
standard bedding (Fig. 11).
The production of proinflammatory cytokines (IL-1β and TNF-β) was comparable in inflamed paw tissue 
cultures from −IRF and +IRF rats (Fig. 11).
On the other hand, the production levels of TGF-β were higher (p ≤ 0.001) in inflamed paw tissue cultures 
from +IRF rats compared with −IRF rats, whereas IL-10 production levels were comparable in inflamed paw 
tissue cultures from these two groups of rats (Fig. 11).
Discussion
The study showed clearly effects of IR cage bedding constructed from Celliant fibre on the burrowing per-
formance (reflecting a global pain score) in CIA rat model. Generally, mechanisms underlying joint pain in 
CIA involve direct action of inflammatory mediators and/or CII-specific antibodies on nociceptors, special-
ized primary afferent sensory neurons in the pain  pathway38,83. Our results, for the first time to the best of our 
knowledge, showed that infrared radiation may diminish the generation of (auto)antigen-specific potentially 
harmful IgG antibodies. By using modified anti-CII antibodies and transgenic or chimeric mice it was estab-
lished that the interaction of these antibodies with the IgG receptor (FcγRI) on sensory  neurons84 is important 
for their pronociceptive  properties38. These findings are suggested to be of translational  value38. In favor of the 
inflammation-independent pronociceptive properties of CII-specific antibodies, are data indicating that: (i) 
joint pain precedes the appearance of visible signs of arthritis in both RA and CIA, and (ii) depending on the 
levels of joint tissue-specific antibodies, the perception of pain may differ between individuals with otherwise 
similar severity of joint  inflammation38. In keeping with these data, our study showed that rats housed in cages 
with IR bedding exhibited less prominent burrowing deficit although clinical arthritis score of the disease was 
Figure 11.  Influence of rat exposure to IR fibre bedding in a treatment paradigm on the production of PGE2, 
NO, and cytokines by carrageenan-inflamed paws. Scatter plots (created using GraphPad Prism version 7.00 for 
Windows, GraphPad Software, La Jolla, California, USA; https ://www.graph pad.com) show PGE2, NO, TNF-α, 
IL-1β, TGF-β and IL-10 production levels in the supernatants from 4 h (PGE2) or overnight carrageenan-
inflamed paw tissue cultures (normalized to the paw weight) (see Material and Methods) from rats transferred 
in cages with IR fibre bedding (+IRF rats) or in cages with standard wooden shaving bedding (−IRF rats) 
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only slightly, but not statistically significantly, lower compared with those housed in cages with standard bed-
ding. However, given that CII-specific antibodies form immune complexes that bind to joint cartilage leading 
to attraction of inflammatory cells (a key step in the development of arthritis)85, their contribution to burrowing 
deficit via promotion of tissue damage and inflammation could not be ruled out. Indeed, our results showed 
the increase in the average volume of the paws (inflammatory parameter which is not included in the arthritic 
score) was lower from +IRF rats compared with their −IRF counterparts. This suggested the beneficial effect 
of infrared radiation on paw swelling. Consequently, the less pronounced compression of edematous fluid on 
nociceptors may be expected. This finding most likely did not solely reflect the effect of infrared radiation on 
the degree of CII-specific antibody-mediated tissue injury, but possibly also its influence on the paw infiltra-
tion with monocytes/macrophages, as suggested by analysis of CD11b + cell migration in the painting test. To 
the best of our knowledge, there is no data on the influence of infrared radiation on monocyte/macrophage 
migration. However, there is data indicating that short exposure to near-infrared laser light may influence the 
migration of migratory dendritic  cells86. Thus, it may be speculated that the rat exposure to infrared radiation 
from IR bedding impaired CD11 + dendritic cell migration into DLN. This could affect follicular helper T cell 
priming and consequently their capacity to provide help to the cognate germinal center B cells to differentiate 
into antibody-producing plasma  cells88. To corroborate this assumption, our results showed that the exposure to 
IR fibres down-regulated the expression of CCL19 and CCL21, the key chemokines governing not only dendritic 
cell migration, but also their positioning within DLN, which is crucial for their interactions with T cells and 
productive T cell  response87,88. Additionally, in favor of our assumption could be also added that the produc-
tion of IL-17, Th17 signature cytokine, was diminished in inflamed paw cultures from +IRF rats compared with 
their −IRF counterparts. Furthermore, considering that the development of autoimmune response-induced 
damage and consequently inflammation critically depends on the magnitude of the autoimmune response in 
LN draining the site of  immunisation89, the delayed appearance of the first signs of inflammation in +IRF rats 
compared with their –IRF counterparts is also consistent with the negative influence of infrared radiation from 
IR cage bedding on the development of humoral and cellular autoimmune response in this rat CIA model. To 
corroborate different effects of the infrared radiation on dendritic cell and monocyte/macrophage migration are 
data indicating that their migration is influenced by many  factors90, and that all of them are not equally important 
for these two types of innate immunity  cells66.
To further assess mechanisms underlying the development of autoimmune inflammation and inflammatory 
pain in CIA, the production levels of inflammatory mediators in inflamed paw culture supernatants (mimicking 
their content in “inflammatory soup”) were examined. The results showed that the infrared radiation-induced 
changes in the production of inflammatory mediators were the mediator specific. Namely, the decrease in the 
levels of proinflammatory mediators  (PGE2 and NO) was followed by the increase in the levels of anti-inflam-
matory/immunoregulatory mediators (IL-10 and TGF-β), suggesting that infrared radiation did not affect only 
autoimmune response, but also inflammatory response. Considering the central role of monocytes/macrophages 
in inflammation in RA/CIA22, the shift in the inflammatory mediator profile in supernatants from inflamed CIA 
rat paws could be related to the enhanced phagocytic capacity of CD11b + cells from +IRF rats compared with 
their −IRF counterparts. Namely, the phagocytosis of apoptotic cells has been shown to change monocytes/
macrophages secretory profile from pro-inflammatory into anti-inflammatory/immunoregulatory  profile91. 
Several lines of findings taken conjointly support our results. Firstly, far infrared radiation was shown to aug-
ment  phagocytosis92. Secondly, even short-term exposure of mice affected by chemically induced peritonitis to 
far infrared radiation may decrease the production of pro-inflammatory mediators by peritoneal  macrophages9 
Thirdly, endothelial cell exposure to far infrared radiation in vitro enhanced the expression of heme oxyge-
nase-110, the enzyme promoting anti-inflammatory response of monocytes/macrophages93–95. In keeping with our 
findings suggesting anti-inflammatory (independent on immunomodulatory) action of infrared radiation from 
cage bedding are data indicating that far infrared radiation from bioceramics may produce an anti-inflammatory 
effect on lipopolysaccharide-induced knee joint arthritis in  rabbits96. Moreover, it should be pointed that the 
reduced NO production in inflamed tissues from +IRF rats could contribute to the less prominent inflamma-
tory response in +IRF rats through lessening NO-mediated breakdown of cartilage  tissue97,98. To add additional 
weight to our finding are data indicating that the exposure to far infrared radiation may negatively affect NO 
synthesis in inflamed  tissue9.
To further evaluate the anti-inflammatory properties of infrared radiation, we investigated the development 
of CIPI in rats transferred to cages with bedding constructed from IR fibres five days before carrageenan admin-
istration. We found that paw inflammation (judging by the increase in paw volume, and paw pain) was markedly 
less prominent in these rats compared with their counterparts from cages with standard bedding. The analysis of 
inflammatory mediator production in carrageenan-inflamed paw cultures showed that the exposure to infrared 
radiation led to the shift in inflammatory mediator profile towards a more anti-inflammatory/immunomodula-
tory phenotype, as the production levels of  PGE2 and IL-1β decreased, whereas that of TGF-β increased. This 
finding may indicate that the effects of infrared radiation from IR ceramic particles incorporated into fibres on 
inflammatory mediator production depend on the type of inflammation and/or duration of the exposure period. 
It should be underscored that the exposure of rats to IR fibres immediately after carrageenan administration 
(treatment paradigm) also reduced the paw edema and exerted a beneficial effect on both mechanical-stimulus 
evoked pain (as shown by von Frey test) and burrowing performance. These effects of infrared radiation were 
less prominent than those induced by Diklofen. However, given that nonsteroidal anti-inflammatory drugs, 
including diclofenac, cannot entirely control severe joint pain in RA and that these drugs have (particularly 
at higher doses) many side-effects, it is highly likely that a combination of the exposure of inflamed joints to 
IR emitting material and usage of non-steroidal inflammatory drugs could (i) be more efficient in the control 
of this RA symptom than usage of nonsteroidal anti-inflammatory drugs alone and (ii) allow usage of these 
drugs at lower doses to achieve the optimal therapeutic effect. According to our literature search, the effects of 
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infrared radiation on inflammation/pain have not been compared in other studies. The analysis of inflammatory 
mediator production in carrageenan-inflamed paw cultures showed that the exposure to IR fibres in the treat-
ment paradigm also decreased the production of proinflammatory mediators  (PGE2 and NO), but increased 
the production of TGF-β. Thus, it may be speculated that effects of infrared radiation from Celliant fibres on 
inflammatory mediator production depends on the duration of exposure to these fibres, although the influence 
of the temporal relationship between the treatment initiation and inflammatory stimulus application could not 
be completely excluded.
Furthermore, it should be pointed out that infrared radiation could influence the pain behaviour of CIA 
and CIPI rats, not only by reducing the intensity of inflammation and consequently the degree of tissue edema, 
but also by modulating the secretion of inflammatory mediators, which modulate the peripheral and central 
nervous sensitization and thereby nociception. The reduced level of  PGE2, a classic lipid inflammatory mediator 
shown to exert algogenic effects by increasing peripheral and central nervous  sensitization83, in paw cultures 
from +IRF rats could be associated with inhibitory effects of far infrared radiation from ceramic material on 
cyclooxygenase-2 expression and  PGE2 synthesis by cultured macrophages and/or chondrocyte cell  lines99. It 
should be pointed out that  PGE2 may also exert pro-nociceptive effects indirectly, by promoting the differentia-
tion of Th cells producing IL-17100. Thus, the reduced production of IL-17 in paw cultures from CIA rats seems 
to be consistent with the reduced  PGE2 production. It should be added that IL-17 does not have only an essential 
role in the development of joint inflammation and thereby in the inflammatory pain in CIA-affected  rats28, but 
also participate in the development of joint pain through sensitization of sensory  neurons101. Additionally, in 
rats suffering from CIPI, the reduced production of IL-1β may contribute to the moderating effects of IR fibres 
on inflammatory pain. In favor of this assumption are findings indicating that exposure to infrared radiation 
from a pad impregnated with IR ceramic placed on the bottom of the housing unit decreases IL-1β production 
in skin tissue from paws administered with complete Freund’s adjuvant to induce  inflammation102. Furthermore, 
beneficial effects of infrared radiation from cage bedding on rat pain behaviour in both CIA and CIPI models 
may reflect the enhanced production of IL-10 and/or TGF-β in inflamed tissue, as they are shown to moderate 
peripheral and central sensory nerve sensitization, and thereby  nociception103–106. To support this notion are 
data indicating that the exposure to far infrared radiation from ceramic materials diminishes IL-10 production 
from complete Freund’s adjuvant-inflamed mice  paws102. In favor of the contribution of diminished production 
of TGF-β in inflamed tissues to the moderating effect of infrared radiation from cage bedding on inflammatory 
pain in CIA and CIPI models are literature reports indicating that: (i) TGF-β family members act as modula-
tors of acute and chronic pain perception through the transcriptional regulation of genes encoding endogenous 
 opioids106, and (ii) the anti-hyperalgesic effects of IR ceramics involve the opioid  system107.
Finally, it should be pointed that CIA is associated with adverse changes in the blood redox state reflecting not 
only joint cartilage destruction, but also the development of inflammatory changes in other tissues or  organs108. 
Thus, the increased burrowing capacity, reflecting reduced global pain score and consequently better animal 
 welfare46 in +IRF rats compared with their −IRF counterparts was consistent with the improved redox status 
in their blood, as indicated by PAB. This finding was corroborated by previous studies indicating the beneficial 
effects of IR ceramics on the systemic levels of oxidative stress  biomarkers109.
In conclusion, our study (i) showed that the exposure of rats to infrared radiation from IR cage-bedding 
moderates the development of autoimmune joint inflammation, and consequently has beneficial effects on 
global spontaneous pain score and welfare and (ii) pointed to rather complex immunomodulatory and anti-
inflammatory mechanisms underlying this phenomenon. While further translational studies are warranted, our 
findings support the use of infrared emitting bed linen, bandages, or garments as adjuvant non-pharmacological 
treatments for RA patients, and possibly for those suffering from other inflammatory antibody-mediated auto-
immune diseases. Additionally, the study showed that the exposure to such infrared radiation may have also 
beneficial effect on the development of sterile inflammation and the inflammatory pain, as well as a therapeutic 
effect when a sterile inflammation is induced; the findings that also may have significant translatory value.
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